Chiche, Johanna <br/><br/>
GAPDH Expression Predicts the Response to R-CHOP, the Tumor Metabolic Status, and the Response of DLBCL Patients to Metabolic Inhibitors.  [electronic resource] 

 -  Cell metabolism  06 2019 
 - 1243-1257.e10 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1932-7420 
<br/><br/><label>Standard No.: </label>10.1016/j.cmet.2019.02.002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Animals<br/>Antimetabolites, Antineoplastic--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Cells, Cultured<br/>Cohort Studies<br/>Cyclophosphamide--therapeutic use<br/>Doxorubicin--therapeutic use<br/>Female<br/>Gene Expression Regulation, Enzymologic<br/>Gene Expression Regulation, Neoplastic<br/>Glyceraldehyde-3-Phosphate Dehydrogenases--genetics<br/>HEK293 Cells<br/>Humans<br/>Lymphoma, Large B-Cell, Diffuse--diagnosis<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Transgenic<br/>Middle Aged<br/>Prednisone--therapeutic use<br/>Prognosis<br/>Retrospective Studies<br/>Rituximab--therapeutic use<br/>Treatment Outcome<br/>Vincristine--therapeutic use<br/>Young Adult